Presentation Information

[2P-231]The Therapeutic Potential of (R)-Carvedilol in Huntington’s Disease Through Enhancement of Autophagy-Lysosomal Pathway via GSK-3β Inhibition

*Tz Chuen Ju1,2, Chih Yuan Cheng3,4, Kai Po Chen1,3 (1. Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan, 2. Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, 3. Department of Animal Science and Biotechnology, Tunghai University, Taichung, Taiwan, 4. Graduate Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan)

Keywords:

autophagy-lysosomal pathway (ALP),glycogen synthase 3β (GSK-3β),mutant huntingtin (mHTT),transcription factor binding to IGHM enhancer 3 (TFE3)

Password required to view

Please enter the password that will be sent to those who have paid the meeting participation fee.
*For free participants, the password will be sent after confirmation and approval by the meeting secretariat.
*For on-the-day cash payments, the password is printed on your name badge.

Comment

To browse or post comments, you must log in.Log in